SINGAPORE,March 5,2025-- In a significant development for the clinical diagnostics landscape in Singapore,Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova)
PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.
Witness the power of advanced automation,multi-orbit connectivity and cloud-driven scalability in action
BEIJING,March 3,2025-- On March 2,Yuwell Medical and the CFA Team China announced an official partnership at a signing ceremony in Beijing under the theme "Elevating Health Celebrating Sport.&quo
SAN DIEGO,March 3,2025-- Longbio Pharma (Suzhou) Co.,Ltd. (referred to as "Longbio"),a leading biotech company dedicated to developing innovative biologic treatments for allergy,respiratory,